Efficacy of omegacin for fibrile neutropenia

Efficacy of omegacin for fibrile neutropenia - fibrile neutropenia and omegacin

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009368

Enrollment

Registered

2012-11-20

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fibrile neutripenia

Interventions

omegacin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: fibrile neutropenia

Exclusion criteria

Exclusion criteria: serious abnormality of heart, liver and renal function allergy

Design outcomes

Primary

Measure	Time frame
efficacy	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026